drugset / Trial / NCT04811469
Safety, Tolerability and Pharmacokinetics of CBP-174 in Healthy Adults
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of CBP-174 after a single oral dose in healthy adult subjects.
Timeline
- Start
- 2021-05-24
- Primary completion
- 2022-05-14
- Completion
- 2022-05-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CBP-174 | Unknown | — | Oral |
Indications
No indication recorded.